REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,075 | -45.5% | 8,289 | +20.3% | 0.00% | -42.9% |
| Q2 2023 | $174,361 | -16.2% | 6,889 | +6.6% | 0.01% | -12.5% |
| Q1 2023 | $208,109 | -3.9% | 6,461 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $216,508 | +50.4% | 6,461 | +20.5% | 0.01% | +50.0% |
| Q3 2022 | $144,000 | +94.6% | 5,362 | 0.0% | 0.01% | +100.0% |
| Q2 2022 | $74,000 | -29.5% | 5,362 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $105,000 | +19.3% | 5,362 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $88,000 | -40.9% | 5,362 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $149,000 | -6.3% | 5,362 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $159,000 | +6.0% | 5,362 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $150,000 | -1.3% | 5,362 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $152,000 | +12.6% | 5,362 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $135,000 | +9.8% | 5,362 | +6.9% | 0.01% | 0.0% |
| Q2 2020 | $123,000 | +105.0% | 5,017 | +24.2% | 0.01% | +100.0% |
| Q1 2020 | $60,000 | -1.6% | 4,039 | +7.1% | 0.00% | 0.0% |
| Q4 2019 | $61,000 | +24.5% | 3,771 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $49,000 | 0.0% | 3,771 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $49,000 | +8.9% | 3,771 | +33.2% | 0.00% | 0.0% |
| Q1 2019 | $45,000 | -21.1% | 2,832 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $57,000 | -18.6% | 2,832 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $70,000 | -10.3% | 2,832 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $78,000 | +11.4% | 2,832 | +24.6% | 0.00% | +33.3% |
| Q1 2018 | $70,000 | 0.0% | 2,272 | +15.4% | 0.00% | 0.0% |
| Q4 2017 | $70,000 | +45.8% | 1,969 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $48,000 | -7.7% | 1,969 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $52,000 | +73.3% | 1,969 | +38.0% | 0.00% | +200.0% |
| Q1 2017 | $30,000 | – | 1,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |